Takanori Teshima mainly focuses on Immunology, Transplantation, Graft-versus-host disease, Bone marrow and T cell. His research in Immunology intersects with topics in Hematopoietic stem cell transplantation and Stem cell. His Transplantation research entails a greater understanding of Internal medicine.
Takanori Teshima has included themes like Gastroenterology, Surgery and Oncology in his Internal medicine study. The study incorporates disciplines such as Biomarker, Autoimmune disease, Major histocompatibility complex and Pathogenesis in addition to Graft-versus-host disease. His Bone marrow research integrates issues from Viral disease, Virus, Herpesviridae and Interleukin 11.
Takanori Teshima focuses on Immunology, Internal medicine, Transplantation, Hematopoietic stem cell transplantation and Graft-versus-host disease. His Immunology research incorporates elements of Haematopoiesis and Stem cell. His work deals with themes such as Gastroenterology, Surgery and Oncology, which intersect with Internal medicine.
The Transplantation study combines topics in areas such as Survival rate, Transplantation Conditioning, Cyclophosphamide and Hazard ratio. His Hematopoietic stem cell transplantation research includes themes of Complication and Immune system. His Graft-versus-host disease study improves the overall literature in Disease.
Takanori Teshima mainly focuses on Internal medicine, Gastroenterology, Transplantation, Hematopoietic stem cell transplantation and Oncology. His Hematology, Graft-versus-host disease, Diffuse large B-cell lymphoma and Cumulative incidence study in the realm of Internal medicine connects with subjects such as In patient. His work carried out in the field of Graft-versus-host disease brings together such families of science as Hazard ratio, Acute leukemia and Calcineurin.
The various areas that he examines in his Gastroenterology study include Phases of clinical research, Cyclophosphamide, Retrospective cohort study, Neutrophil Engraftment and Thymoglobulin. His Transplantation study incorporates themes from Hematopoietic cell, Leukemia, Immunology, Bone marrow and Disease. Takanori Teshima interconnects Myeloid leukemia, Complication and Pharmacology in the investigation of issues within Hematopoietic stem cell transplantation.
Takanori Teshima mostly deals with Internal medicine, Transplantation, Gastroenterology, Oncology and Saliva. His study focuses on the intersection of Internal medicine and fields such as Stem cell with connections in the field of Clinical trial. His biological study spans a wide range of topics, including Leukemia, Immunology and Disease.
His work on Dysbiosis is typically connected to Lactose as part of general Immunology study, connecting several disciplines of science. The concepts of his Gastroenterology study are interwoven with issues in Incidence, Retrospective cohort study, Risk factor and Acute leukemia. His Graft-versus-host disease research is multidisciplinary, relying on both Regimen and Calcineurin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Acute graft-versus-host disease does not require alloantigen expression on host epithelium
Takanori Teshima;Rainer Ordemann;Pavan Reddy;Svetlana Gagin.
Nature Medicine (2002)
TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
Yoshikane Kikushige;Takahiro Shima;Shin Ichiro Takayanagi;Shingo Urata.
Cell Stem Cell (2010)
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.
Kenneth R. Cooke;Armin Gerbitz;James M. Crawford;Takanori Teshima.
Journal of Clinical Investigation (2001)
Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.
Geoffrey R. Hill;Kenneth R. Cooke;Takanori Teshima;James M. Crawford.
Journal of Clinical Investigation (1998)
Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins.
Yoshihiro Eriguchi;Shuichiro Takashima;Hideyo Oka;Sonoko Shimoji.
Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease
Ulrich A. Duffner;Yoshinobu Maeda;Kenneth R. Cooke;Pavan Reddy.
Journal of Immunology (2004)
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Sally Arai;Mukta Arora;Tao Wang;Tao Wang;Stephen R. Spellman.
Biology of Blood and Marrow Transplantation (2015)
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease
James L.M. Ferrara;Andrew C. Harris;Joel K. Greenson;Thomas M. Braun.
Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia
Geoffrey R. Hill;Takanori Teshima;Takanori Teshima;Armin Gerbitz;Luying Pan.
Journal of Clinical Investigation (1999)
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
Jonathan U Peled;Antonio L C Gomes;Sean M Devlin;Eric R Littmann.
The New England Journal of Medicine (2020)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: